I Sathyamurthy
About
In The Last Decade
I Sathyamurthy
62 papers receiving 336 citations
Peers
Comparison fields: 5 of 74
- Cardiology and Cardiovascular Medicine 222
- Surgery 93
- Epidemiology 62
- Endocrinology, Diabetes and Metabolism 53
- Radiology, Nuclear Medicine and Imaging 41
Countries citing papers authored by I Sathyamurthy
This map shows the geographic impact of I Sathyamurthy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I Sathyamurthy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I Sathyamurthy more than expected).
Fields of papers citing papers by I Sathyamurthy
This network shows the impact of papers produced by I Sathyamurthy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I Sathyamurthy. The network helps show where I Sathyamurthy may publish in the future.
Co-authorship network of co-authors of I Sathyamurthy
This figure shows the co-authorship network connecting the top 25 collaborators of I Sathyamurthy. A scholar is included among the top collaborators of I Sathyamurthy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I Sathyamurthy. I Sathyamurthy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 11 | |
| 5 | 34 | |
| 6 | Pharmacological Reperfusion Therapy with Tenecteplase in 7,668 Indian Patients with ST Elevation Myocardial Infarction - A Real World Indian Experience. | 0 |
| 7 | 4 | |
| 8 | Comparison of plasma adiponectin & certain inflammatory markers in angiographically proven coronary artery disease patients with & without diabetes - A study from India | 1 |
| 9 | 0 | |
| 10 | 5 | |
| 11 | Efficacy & safety of tenecteplase in 6000 patients with ST-elevation myocardial infarction from the Elaxim Indian Registry. | 3 |
| 12 | 6 | |
| 13 | Efficacy and safety of tenecteplase in Indian elderly STEMI patients from the Elaxim Indian Registry. | 1 |
| 14 | 2 | |
| 15 | 4 | |
| 16 | Efficacy and safety of tenecteplase in ST elevation myocardial infarction patients from the Elaxim Indian Registry. | 5 |
| 17 | Efficacy and safety of tenecteplase in diabetic and non-diabetic patients of STEMI - Indian registry data. | 1 |
| 18 | Efficacy and safety of tenecteplase in Indian patients with st-segment elevation myocardial infarction. | 3 |
| 19 | Plasma homocysteine concentration and coronary artery disease in Asian Indians. | 10 |
| 20 | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.